Daytrana Side Effects

Some side effects of Daytrana might not be reported. Always talk to your physician or health care specialist for medical health advice. You may even report side effects towards the Food and drug administration.

 

For that Consumer

Is applicable to methylphenidate: dental capsule extended release, dental powder for suspension extended release, dental solution, dental tablet, dental tablet chewable, dental tablet extended release

Other dosage forms:

• transdermal patch extended release

Together with its needed effects, methylphenidate (the active component found in Daytrana) could cause some undesirable effects. Although not every one of these side effects can happen, when they occur they might need medical assistance.

Seek advice from your physician immediately if the following side effects occur while taking methylphenidate:

More prevalent

• Fast heartbeat

Less frequent

• Chest discomfort


• fever


• joint discomfort


• skin rash or hives

Rare

• Black, tarry stools


• bloodstream within the urine or stools


• blurred vision or any other alterations in vision


• withdrawal leading to convulsions


• crusting, dryness, or flaking of your skin


• muscle cramps


• pinpoint red-colored spots onto the skin


• scaling, severe redness, tenderness, or swelling of your skin


• out of control vocal reactions or tics (out of control and repeated body actions)


• unusual bleeding or bruising

Incidence unfamiliar

• Confusion


• feeling like surroundings aren't real


• depression


• hives or welts


• numbness from the hands


• painful or difficult peeing


• pale skin


• paleness or cold perspective of tips of the fingers and toes


• red-colored, inflammed eyes


• red-colored, inflamed, or scaly skin


• seeing, hearing, or feeling things that aren't there


• severe or sudden headache


• difficulty breathing


• sores, stomach problems, or whitened spots around the lips or perhaps in the mouth


• sudden lack of coordination


• sudden slurring of speech


• tingling or discomfort within the fingers or toes when uncovered to cold


• unusual behavior


• unusual fatigue or weakness


• weight reduction


• yellow skin or eyes

Some side effects of methylphenidate can happen that tend not to need medical assistance. These side effects might have to go away throughout treatment as the body changes towards the medicine. Also, your healthcare professional may have the ability to let you know about methods to prevent or reduce a few of these side effects. Seek advice from your healthcare professional if the following side effects continue or are annoying or you have questions regarding them:

More prevalent

• Abdominal or stomach discomfort


• headache


• appetite loss


• anxiety


• stuffy nose


• sleep problems


• abnormally warm skin

Less frequent

• Anger


• lightheadedness


• sleepiness


• fear


• irritability


• muscle aches


• nausea


• runny nose


• scalp hair thinning


• speaking, feeling, and acting readily

For Health care Professionals

Is applicable to methylphenidate: dental capsule extended release, dental powder for reconstitution extended release, dental solution, dental tablet, dental tablet chewable, dental tablet extended release, transdermal film extended release

Central nervous system

Central nervous system side effects have frequently incorporated tic. Withdrawal leading to convulsions and migraine are also reported. Lightheadedness, sleepiness, dyskinesia, and Tourette's syndrome happen to be reported rarely. Neuroleptic malignant syndrome (NMS) and reversible ischemic nerve deficit happen to be reported hardly ever.

Most reported installments of neuroleptic malignant syndrome (NMS) involved patients who have been treated concomitantly along with other drugs connected with NMS. Anxiety and insomnia might be controlled by reduction of the dosage and omitting the drug within the mid-day or evening. It's unclear whether CNS stimulant drugs (i.e., dextroamphetamine, methylphenidate, amphetamine-dextroamphetamine) contribute either in the expansion or worsening of tic disorders for example Tourette's syndrome. Based on several situation reviews, utilization of CNS stimulant medicines might have precipitated or amplified tic disorders in certain patients with Attention deficit hyperactivity disorder. According to these cases, in Tourette's-susceptible patients, CNS stimulants may exacerbate motor and phonic tics that don't subside following discontinuation from the problem agent. In a number of controlled studies including patients with Attention deficit hyperactivity disorder and tic disorders, in nearly all patients, tics didn't increase following utilization of CNS stimulants. Additionally, controlled studies haven't discovered that methylphenidate gets worse motor tics in Tourette's syndrome nor has it elevated tics in patients without Tourette's. However, it ought to be noted that tics were reported in 7% of patients while using methylphenidate patch in comparison to at least onePercent to individuals taking it orally. Additional research is needed to be able to clarify this association.

Intestinal

Intestinal side effects have incorporated nausea, vomiting, and abdominal discomfort. Vomiting and nausea seems to happen more often using the transdermal patch in comparison with dental administration. Postmarketing side effects include bruxism.

Cardiovascular

Cardiovascular side effects have rarely incorporated alterations in bloodstream pressure and pulse rate, cerebral arteritis, occlusion, angina, arrhythmia, heart palpitations, bradycardia, extrasystoles, ventricular extrasystoles, supraventricular tachycardia, Raynaud's phenomenon, and tachycardia. A situation of cardiac event has additionally been reported. Furthermore, cerebrovascular vasculitis, cerebral hemorrhages, and cerebrovascular accidents happen to be reported.

Other

Other side effects have rarely incorporated headache, peripheral coldness, and auricular swelling. A withdrawal syndrome continues to be reported using the abrupt discontinuation of methylphenidate (the active component found in Daytrana)

Hepatic

Hepatic side effects have rarely incorporated abnormal liver function varying from transaminase elevation to hepatic coma however, causality is not established. Elevated bloodstream alkaline phosphatase, elevated bloodstream bilirubin, and elevated hepatic enzymes are also reported.

Hematologic

Hematologic side effects have rarely incorporated leukopenia, anemia, pancytopenia, thrombocytopenic purpura, and thrombocytopenia however, causality is not established.

Psychological

Psychological side effects have frequently incorporated emotional lability and insomnia. Hallucination, mania, obsessive-compulsive disorder, and anxiety are also reported. Emotional lability and insomnia seem to occur more often using the transdermal patch in comparison with dental administration. In patients putting on the transdermal patch for 12 several hours each day, the incidence of insomnia was 30%. Transient depressed mood and aggressive behavior happen to be reported rarely however, causality is not determined. Postmarketing side effects include logorrhea.

Dermatologic

Dermatologic side effects have incorporated bullous conditions, exfoliative conditions, urticarias, pruritus, breakouts, eruptions, erythema, and exanthemas. Scalp hair thinning continues to be reported rarely however, causality is not determined.

Methylphenidate topical patch is really a skin irritant. The resulting erythema doesn't typically cause an interference or discontinuation of treatment. However, further evaluation ought to be searched for, if erythema, edema, and/or papules don't resolve or considerably reduce within 24 hrs of patch removal. Consideration ought to be provided to sensitization if erythema is supported by edema, papules, vesicles, or any other proof of more serious local responses. Proper diagnosis of allergic contact dermatitis will include appropriate diagnostic testing.

Ocular

Ocular side effects have incorporated visual disturbances, mydriasis, problems with accommodation, diplopia, and clouding of vision.

Respiratory system

Respiratory system side effects connected with methylphenidate (the active component found in Daytrana) topical patch have frequently incorporated nasopharyngitis and nasal congestion.

Metabolic

Metabolic side effects have incorporated anorexia, decreased appetite, and weight reduction (mainly with prolonged therapy). Anorexia, decreased appetite, and weigh loss seems to happen more often using the transdermal patch in comparison with dental administration. In patients putting on the transdermal patch for 12 several hours each day, the incidence of anorexia was 46%.

Local

Local side effects connected using the topical patch have incorporated application site responses for example bleeding, bruising, burn, burning, dermatitis, discharge, discoloration, discomfort, dryness, eczema, edema, erosion, erythema, excoriation, exfoliation, fissure, hyperpigmentation, hypopigmentation, induration, infection, inflammation, irritation, discomfort, papules, paresthesia, pruritus, rash, scab, swelling, ulcer, urticaria, vesicles, and heat.

Hypersensitivity

Hypersensitivity side effects including generalized erythematous and urticarial breakouts, allergic contact dermatitis, angioedema, and anaphylaxis happen to be reported.

One subject continues to be reported to possess experienced erythema and edema at methylphenidate transdermal system application sites with concurrent urticarial lesions around the abdomen and legs leading to treatment discontinuation. This subject wasn't moved forward to dental methylphenidate.

Bone and joint

Bone and joint side effects including arthralgia, myalgia, and muscle twitching happen to be reported.

Genitourinary

Genitourinary side effects have incorporated in rare instances prolonged or painful hardons referred to as priapism.